Deposits and Payment for Drug Product and Development Sample Clauses

Deposits and Payment for Drug Product and Development. Promptly upon execution of each Project Plan, CLIENT shall pay to AXXXXX forty percent (40%) of the total fees of this agreement, and thereafter will be invoiced monthly based on the specific services completed during the month. The final invoice for the Drug Product will be issued upon the delivery of released Drug Product to CLIENT by AXXXXX CLIENT shall pay all invoices within thirty (30) days of the invoice date therefore. Any payment due under this Agreement not received within the times noted above shall bear interest at the lesser of (a) the maximum rate permitted by law, and (b) 1.5% per month on the outstanding balance compounded monthly.

AutoNDA by SimpleDocs

Deposits and Payment for Drug Product and Development. Promptly upon execution of each Project Plan, CLIENT shall pay to AXXXXX [†] of the total fees of each Project Plan, unless otherwise set forth in the Project Plan. Thereafter, AXXXXX will invoice CLIENT monthly based on the specific services completed and/or milestones met during the month. A payment schedule may be set forth in each Project Plan. CLIENT shall pay all invoices within thirty (30) days of receipt by CLIENT. Any payment due under this Agreement not received within the times noted above shall bear interest at the lesser of (a) the maximum rate permitted by law, and (b) 1.5% per month on the outstanding balance compounded monthly. Not withstanding the above provisions of this Section 2.11, CLIENT may withhold until resolved payment of any invoices that are disputed in good faith due to any Drug Product or other deliverable failing to meet standards set forth in the applicable Project Plan.

Deposits and Payment for Drug Product and Development. Promptly after execution of each Development Plan and Project Plan, NTI shall pay to BPS the deposit, if any, set *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. CONFIDENTIAL TREATMENT REQUESTED forth therein. After completion of each phase of Development as set forth in the applicable Development Plan or Project Plan, BPS shall invoice NTI for the Development costs for such phase, as set forth in the applicable Development Plan or Project Plan. NTI shall pay such Development costs within *** days of each such invoice date. Upon completion of the filling of a Batch of Drug Product, BPS shall invoice NTI for the Purchase Price for such Batch, as set forth in the Project Plan. NTI shall make payment within *** days of such invoice date for such Batch of Drug Product. Any payment due under this Agreement that is not made by NTI within the time periods noted above shall bear interest at the lesser of (a) the maximum rate permitted by law, and (b) *** per *** on the outstanding balance.

Deposits and Payment for Drug Product and Development. Promptly upon execution of each Project Plan, CLIENT shall pay to XXXXXX forty percent (40%) of the total fees of this agreement, and thereafter will be invoiced monthly based on the specific services completed during the month. The final invoice for the Drug Product will be issued upon the delivery of released Drug Product to CLIENT by XXXXXX CLIENT shall pay all invoices within thirty (30) days of the invoice date therefore. Any payment due under this Agreement not received within the times noted above shall bear interest at the lesser of (a) the maximum rate permitted by law, and

Related to Deposits and Payment for Drug Product and Development

Orally Administered Anticancer Medication In accordance with RIGL § 27-20-67, prescription drug coverage for orally administered anticancer medications is provided at a level no less favorable than coverage for intravenously administered or injected cancer medications covered under your medical benefit.
Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.
Payment for Labor and Materials The Contractor agrees and binds itself to pay for all labor done, and for all the materials used in the construction of the work to be completed pursuant to this contract.
Particular Methods of Procurement of Goods and Works International Competitive Bidding. Goods and works shall be procured under contracts awarded on the basis of International Competitive Bidding.
PAYMENT FOR GOODS AND SERVICES a. DIR Customer shall comply with Chapter 2251, Texas Government Code, or applicable local law, in making payments to the Vendor. Payment under a DIR Contract shall not foreclose the right to recover wrongful payments.
Creation and Development Fee If the Prospectus related to a Trust specifies a creation and development fee, the Trustee shall, on or immediately after the end of the initial offering period, withdraw from the Capital Account, an amount equal to the unpaid creation and development fee as of such date and credit such amount to a special non-Trust account designated by the Depositor out of which the creation and development fee will be distributed to the Depositor (the "Creation and Development Account"). The creation and development fee is the per unit amount specified in the Prospectus for the Trust.
Non-Marketing Purposes ACROSS SPECIALTY PHARMACY greatly respects your privacy. We do maintain and reserve the right to contact you if needed for non-marketing purposes (such as bug alerts, security breaches, account issues, and/or changes in ACROSS SPECIALTY PHARMACY products and services). In certain circumstances, we may use our website, newspapers, or other public means to post a notice. Children under the age of 13 ACROSS SPECIALTY PHARMACY's website is not directed to, and does not knowingly collect personal identifiable information from, children under the age of thirteen (13). If it is determined that such information has been inadvertently collected on anyone under the age of thirteen (13), we shall immediately take the necessary steps to ensure that such information is deleted from our system's database, or in the alternative, that verifiable parental consent is obtained for the use and storage of such information. Anyone under the age of thirteen (13) must seek and obtain parent or guardian permission to use this website.
Particular Methods of Procurement of Goods Works and Services (other than Consultants’ Services)
Health Promotion and Health Education Both parties to this Agreement recognize the value and importance of health promotion and health education programs. Such programs can assist employees and their dependents to maintain and enhance their health, and to make appropriate use of the health care system. To work toward these goals:
DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.